BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11323380)

  • 1. Composition of CO(2) absorbents.
    Mazze RI
    Anesth Analg; 2001 May; 92(5):1356-7. PubMed ID: 11323380
    [No Abstract]   [Full Text] [Related]  

  • 2. The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption.
    Neumann MA; Laster MJ; Weiskopf RB; Gong DH; Dudziak R; Förster H; Eger EI
    Anesth Analg; 1999 Sep; 89(3):768-73. PubMed ID: 10475323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of compound A and carbon monoxide in circle systems: an in vitro comparison of two carbon dioxide absorbents.
    Struys MM; Bouche MP; Rolly G; Vandevivere YD; Dyzers D; Goeteyn W; Versichelen LF; Van Bocxlaer JF; Mortier EP
    Anaesthesia; 2004 Jun; 59(6):584-9. PubMed ID: 15144299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorbents differ enormously in their capacity to produce compound A and carbon monoxide.
    Stabernack CR; Brown R; Laster MJ; Dudziak R; Eger EI
    Anesth Analg; 2000 Jun; 90(6):1428-35. PubMed ID: 10825335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amsorb: a new carbon dioxide absorbent for use in anesthetic breathing systems.
    Murray JM; Renfrew CW; Bedi A; McCrystal CB; Jones DS; Fee JP
    Anesthesiology; 1999 Nov; 91(5):1342-8. PubMed ID: 10551585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Amsorb, sodalime, and Baralyme degradation of volatile anesthetics and formation of carbon monoxide and compound a in swine in vivo.
    Kharasch ED; Powers KM; Artru AA
    Anesthesiology; 2002 Jan; 96(1):173-82. PubMed ID: 11753018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The loss of sevoflurane from a closed breathing system.
    Vagts DA; Lockwood GG
    Anaesthesia; 1997 Jul; 52(7):636-9. PubMed ID: 9244020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound A and carbon monoxide production from sevoflurane and seven different types of carbon dioxide absorbent in a patient model.
    Keijzer C; Perez RS; de Lange JJ
    Acta Anaesthesiol Scand; 2007 Jan; 51(1):31-7. PubMed ID: 17096668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanisms of carbon monoxide production by inhalational agents.
    Coppens MJ; Versichelen LF; Rolly G; Mortier EP; Struys MM
    Anaesthesia; 2006 May; 61(5):462-8. PubMed ID: 16674622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon monoxide production from desflurane, enflurane, halothane, isoflurane, and sevoflurane with dry soda lime.
    Wissing H; Kuhn I; Warnken U; Dudziak R
    Anesthesiology; 2001 Nov; 95(5):1205-12. PubMed ID: 11684991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of inhalational anaesthetics with CO2 absorbents.
    Baum JA; Woehlck HJ
    Best Pract Res Clin Anaesthesiol; 2003 Mar; 17(1):63-76. PubMed ID: 12751549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global warming potential of inhaled anesthetics: application to clinical use.
    Ryan SM; Nielsen CJ
    Anesth Analg; 2010 Jul; 111(1):92-8. PubMed ID: 20519425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of degradation of sevoflurane by a new carbon dioxide absorbent in humans.
    Mchaourab A; Arain SR; Ebert TJ
    Anesthesiology; 2001 Jun; 94(6):1007-9. PubMed ID: 11465591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desflurane and sevoflurane. New volatile anesthetic agents.
    Clarke KW
    Vet Clin North Am Small Anim Pract; 1999 May; 29(3):793-810, viii. PubMed ID: 10332823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New inhalation anesthetics].
    Conzen P; Nuscheler M
    Anaesthesist; 1996 Aug; 45(8):674-93. PubMed ID: 8967581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers.
    Eger EI; Gong D; Koblin DD; Bowland T; Ionescu P; Laster MJ; Weiskopf RB
    Anesth Analg; 1997 Nov; 85(5):1154-63. PubMed ID: 9356118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical factors affecting the production of carbon monoxide from anesthetic breakdown.
    Woehlck HJ; Dunning M; Raza T; Ruiz F; Bolla B; Zink W
    Anesthesiology; 2001 Mar; 94(3):453-6. PubMed ID: 11374605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperatures in soda lime during degradation of desflurane, isoflurane, and sevoflurane by desiccated soda lime.
    Laster MJ; Eger EI
    Anesth Analg; 2005 Sep; 101(3):753-757. PubMed ID: 16115987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic aspects of carbon monoxide formation from volatile anesthetics.
    Baxter PJ; Garton K; Kharasch ED
    Anesthesiology; 1998 Oct; 89(4):929-41. PubMed ID: 9778011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of lithium hydroxide for carbon dioxide absorption prevents formation of compound A during sevoflurane anesthesia].
    Förster H; Behne M; Warnken UH; Asskali F; Dudziak R
    Anaesthesist; 2000 Feb; 49(2):106-12. PubMed ID: 10756964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.